The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
What is Crystalens? Crystalens is an artificial lens implant that, unlike a standard IOL, can treat both a person's cataracts and presbyopia—loss of near and intermediate vision. You probably noticed in your forties that you started to lose some of your up-close vision and had to start wearing reading glasses. Crystalens not only treats your cataracts (a clouding or hardening of your lens); many patients hardly if ever wear glasses after surgery. It does so by recreating accommodation similar to your eye's natural lens. The uniqueCrystalens is designed to allow you to enjoy a fuller, more natural range of vision for most activities, including: reading a book, working on the computer, and driving a car.
Crystalens was modeled after the human eye. Like the natural lens, it is a lens implant that uses the eye muscle to flex and accommodate in order to focus on objects in the environment at all distances. Crystalens dynamically adjusts to your visual needs.
Few patients with Crystalens have experienced problems with glare, halos and night vision. Crystalens focuses only one image to the back of the eye, unlike a multifocal lens that projects multiple images, requiring your brain to "adjust" to the differences.
Crystalens accommodates like the natural lens. After implantation of Crystalens, most patients will see brighter and clearer across a wider range of distances like they did when they were younger.
ONLY FDA-Approved accomodating IOL Crystalens was the first presbyopia correcting IOL introduced into the United States market and is currently the only FDA-approved accommodating IOL. Crystalens addresses the limitations of standard monofocal IOLs and multifocal IOLs by providing the following advantages to patients:
Source: http://crystalens.com/en-us/iscrystalensrightforyou.aspx
8440 Brentwood Blvd., Ste. D
Brentwood, CA 94513